Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Arm Open Labeled Multicentre Phase 1b Dose Escalation Study of Carfilzomib Taken in Combination With Thalidomide and Dexamethasone in Relapsed AL Amyloidosis

NCT02545907 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT02545907
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02545907 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Arm Open Labeled Multicentre Phase 1b Dose Escalation Study of Carfilzomib Taken in Combination With Thalidomide and Dexamethasone in Relapsed AL Amyloidosis
Lead sponsor
University College, London
Phase
Phase 1/2
Overall status
Completed
Start date
September 14, 2017
Completion date
October 21, 2019
Enrollment
10 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

amyloidosis